We'll soon be changing our name to Action FCS. Look out for our new and improved website.
menu

COVID-19

With the developing corona-virus pandemic, patients with FCS may be wondering about their well-being. In line with everybody else, FCS patients should follow government guidance which is being continually updated as the situation develops, and can be found here Patients who also have diabetes must pay attention to the diabetes-specific advice. This page from Diabetes […]
View this article

New routes to clinical diagnosis of FCS

This paper explores the way in which clinical results can separate patients with FCS from patients with severe hypertriglyceridaemia – important when advising on treatment options and where genetic testing is hard to come by, or is very slow.   Differentiating Familial Chylomicronaemia Syndrome from Multifactorial Severe Hypertriglyceridemia by Clinical Profile : Louis St L O’Dea, James […]
View this article

Glybera gets a second chance

This is great news for patients in Canada and then, potentially, the rest of the world. Click through to see the news report.
View this article

European Athersclerosis Society

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement including a detailed section on familial chylomicronaemia syndrome, symptoms and management. Download rare dislipidaemias EAS
View this article
News archive